Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer. [electronic resource]
Producer: 20150417Description: 233-239 p. digitalISSN:- 1090-2422
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Synergism
- Fas Ligand Protein -- metabolism
- HT29 Cells
- HeLa Cells
- Humans
- Interferon-gamma -- pharmacology
- Neoplasms -- drug therapy
- RNA, Messenger -- biosynthesis
- Serine Endopeptidases -- metabolism
- Serine Proteinase Inhibitors -- pharmacology
- Tosyllysine Chloromethyl Ketone -- pharmacology
- Tosylphenylalanyl Chloromethyl Ketone -- pharmacology
- Up-Regulation
- fas Receptor -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.